NASDAQ:CERC
Delisted

Cerecor Stock Signals

etoro logo Buy CERC
*Your capital is at risk
$0.319
+0.0060 (+1.92%)
At Close: May 27, 2022

Latest Data & Signals Issued

Below are some of the latest signals issued for Cerecor Inc.

General

Signal Type Signal Value Data
Score 0.000 61 days ( 55.45 %
Last Price $0.319 1.92 %
Performance History
7 Days
$0.325 $0.319
-1.85%
30 Days
$0.441 $0.319
-27.66%
12 Mos
$2.62 $0.319
-87.82%

7/18

Active Buy Signals

Specific Signals

Short Term
Net score: 19.23
Signal Type Signal Value Importance Data
High / Low Sell Very Low $0.300 - $0.328
Position: 67.86% from low / 32.14% from high · Momentum: -16.47%
Trend - 3 mos -50.58 % High Width: 265.06 %
Pred. range - 3 mos $0.0722 - $0.263 Low -77.37 % - -17.40 %
Volume Direction Sell High Volume: 10 · Direction: 0
Pivot Short Buy Very Low May 25, 2022 - 3 days
RSI Short Pivot Signal Buy Very Low May 23, 2022 - 5 days
Short MA 3 mos Buy Low May 26, 2022 - 2 days
Long MA 3 mos Sell Medium Apr 06, 2022 - 37 days
Short/Long MA 3 mos Sell Medium Apr 11, 2022 - 34 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 37.01
Signal Type Signal Value Importance Data
Trend - 12 mos -82.93 % Very High Width: 279.28 %
Pred. range - 12 mos N/A - $0.121 High -100.00 % - -62.18 %
Short MA 12 mos Buy Very High May 17, 2022 - 9 days
Long MA 12 mos Sell Very High Sep 03, 2021 - 185 days
Short/Long MA 12 mos Sell Very High Sep 10, 2021 - 181 days
Pivot Long Buy Low May 25, 2022 - 3 days
RSI Long Pivot Signal Buy Low May 24, 2022 - 4 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Buy High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT CERECOR INC.
Cerecor
Cerecor Inc., a clinical-stage biopharmaceutical company, develops drugs to treat patients with neurological and psychiatric disorders. It develops CERC-301 that is in Phase II development stage for the adjunctive treatment of patients with major depressive disorder (MDD); CERC-501, which is in Phase II development stage for the adjunctive treatment of MDD, as well as to treat substance use disorders; and CERC-406 that is in preclinical stage to ...
GOLDEN STAR
Ticker Change Signal Date
N
NXDR
$2.27
7.93% Aug 03
MC
$67.08
3.53% Jul 31
FCX
$62.63
10.79% Jul 31
ARW
$212.85
6.58% Jul 30
BIIB
$202.19
2.20% Jul 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE